← 產業報告目錄
Oral Proteins and Peptides Market Share & Trends Analysis Report, By Type of Target Disease Indication (Acromegaly, Celiac Disease, Chronic Idiopathic Constipation, Enteric Hyperoxaluria, Inflammatory Bowel Disease, and Type II Diabetes), Type of Molecule (Protein and Peptide), Type of Biological Target, Type of Mechanism of Action, By Region, and Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-25頁數 170報告編號 INSIGHTACE-c0e9db5921
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Oral Proteins and Peptides Market on a global scale was estimated at USD 6.51 Bn in 2023 and is expected to attain USD 28.17 Bn by 2031, with a projected CAGR of 20.3% between 2024 and 2031.
Oral Proteins and Peptides encompasses therapeutic medicines made from short chains of amino acids, designed for oral administration to leverage their biological properties in treating various ailments. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
Growth is supported by a convergence of factors: rising awareness among end users, continuous product innovation, and the expanding emphasis on efficiency and sustainability within the healthcare sector.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, supported by rapid industrialization and expanding end-user bases.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Oral Proteins and Peptides Market Snapshot
Chapter 4. Global Oral Proteins and Peptides Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031
4.8. Global Oral Proteins and Peptides Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on Oral Proteins and Peptides Industry Trends
Chapter 5. Oral Proteins and Peptides Market Segmentation 1: By Type of Target Disease Indication, Estimates & Trend Analysis
5.1. Market Share by Type of Target Disease Indication, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type of Target Disease Indication:
5.2.1. Acromegaly
5.2.2. Celiac Disease
5.2.3. Chronic Idiopathic Constipation
5.2.4. Enteric Hyperoxaluria
5.2.5. Inflammatory Bowel Disease
5.2.6. Type II Diabetes
Chapter 6. Oral Proteins and Peptides Market Segmentation 2: By Type of Molecule, Estimates & Trend Analysis
6.1. Market Share by Type of Molecule, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type of Molecules:
6.2.1. Protein
6.2.2. Peptide
Chapter 7. Oral Proteins and Peptides Market Segmentation 3: By Type of Biological Target, Estimates & Trend Analysis
7.1. Market Share by Type of Biological Target, 2023 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type of Biological Targets:
7.2.1. GC-C
7.2.2. Insulin Receptor
7.2.3. Oxalate
7.2.4. Others
Chapter 8. Oral Proteins and Peptides Market Segmentation 4: By Type of Mechanism of Action, Estimates & Trend Analysis
8.1. Market Share by Type of Mechanism of Action, 2023 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type of Mechanism of Action:
8.2.1. Receptor Stimulation
8.2.2. Substrate Degradation
8.2.3. Others
Chapter 9. Oral Proteins and Peptides Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Oral Proteins and Peptides Market, Regional Snapshot 2023 & 2031
9.2. North America
9.2.1. North America Oral Proteins and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Oral Proteins and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Disease Indication, 2024-2031
9.2.3. North America Oral Proteins and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Type of Molecule, 2024-2031
9.2.4. North America Oral Proteins and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Type of Biological Target, 2024-2031
9.2.5. North America Oral Proteins and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Type of Mechanism of Action, 2024-2031
9.3. Europe
9.3.1. Europe Oral Proteins and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Oral Proteins and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Disease Indication, 2024-2031
9.3.3. Europe Oral Proteins and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Type of Molecule, 2024-2031
9.3.4. Europe Oral Proteins and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Type of Biological Target, 2024-2031
9.3.5. Europe Oral Proteins and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Type of Mechanism of Action, 2024-2031
9.4. Asia Pacific
9.4.1. Asia Pacific Oral Proteins and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific Oral Proteins and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Disease Indication, 2024-2031
9.4.3. Asia Pacific Oral Proteins and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Type of Molecule, 2024-2031
9.4.4. Asia Pacific Oral Proteins and Peptides Market Revenue (US$ Million) Estimates and Forecasts By Type of Biological Target, 2024-2031
9.4.5. Asia Pacific Oral Proteins and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Type of Mechanism of Action, 2024-2031
9.5. Latin America
9.5.1. Latin America Oral Proteins and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America Oral Proteins and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Disease Indication, 2024-2031
9.5.3. Latin America Oral Proteins and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Type of Molecule, 2024-2031
9.5.4. Latin America Oral Proteins and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Type of Biological Target, 2024-2031
9.5.5. Latin America Oral Proteins and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Type of Mechanism of Action, 2024-2031
9.6. Middle East & Africa
9.6.1. Middle East & Africa Oral Proteins and Peptides Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa Oral Proteins and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Type of Target Disease Indication, 2024-2031
9.6.3. Middle East & Africa Oral Proteins and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Type of Molecule, 2024-2031
9.6.4. Middle East & Africa Oral Proteins and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Type of Biological Target, 2024-2031
9.6.5. Middle East & Africa Oral Proteins and Peptides Market Revenue (US$ Million) Estimates and Forecasts by Type of Mechanism of Action, 2024-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. . AstraZeneca
10.2.1.1. Business Overview
10.2.1.2. Key Product/Service Offerings
10.2.1.3. Financial PerType of Target Disease Indicationance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. Biocon Chiasma
10.2.3. Generex Biotechnology
10.2.4. Novo Nordisk A/S
10.2.5. Allergan
10.2.6. Oramed Pharmaceuticals
10.2.7. Proxima Concepts
10.2.8. Synergy Pharmaceuticals
10.2.9. Tarsa Therapeutics
10.2.10. Sanofi
10.2.11. F. Hoffmann-La Roche Ltd
10.2.12. Novo Nordisk A/S
10.2.13. Abbvie Inc.
10.2.14. Pfizer Inc.
10.2.15. Bausch Health Companies Inc.
10.2.16. Chiesi Farmaceutici S.P.A.
10.2.17. Acadia Pharmaceuticals Inc.
10.2.18. Aurinia Pharmaceuticals Inc.
10.2.19. Merck & Co., Inc.
10.2.20. Johnson & Johnson Services, Inc.
10.2.21. Swk Holdings
10.2.22. R-Pharm Jsc
10.2.23. Entera Bio Ltd.
10.2.24. Proxima Concepts
10.2.25. AstraZeneca Plc
10.2.26. Regor Therapeutics Group
10.2.27. Terns Pharmaceuticals, Inc.
10.2.28. Structure Therapeutics
10.2.29. Viking Therapeutics
10.2.30. Protagonist Therapeutics Inc.
10.2.31. Rani Therapeutics
10.2.32. Carmot Therapeutics, Inc.
10.2.33. Zealand Pharma
10.2.34. Sciwind Biosciences Co., Ltd.
10.2.35. Jiangsu Hengrui Pharmaceuticals Co., Ltd
10.2.36. Corning Incorporated
10.2.37. Other Market Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們